(Q54280116)

27 May 2018

title

High concordance of EGFR mutation status between histologic and corresponding cytologic specimens of lung adenocarcinomas. (English)

1 reference

27 May 2018

1 reference

5

Sanghoon Jheon

1 reference

27 May 2018

Choon-Taek Lee

4

object named as

Choon-Taek Lee

1 reference

27 May 2018

author name string

Ping-Li Sun

1

1 reference

27 May 2018

Yan Jin

2

1 reference

27 May 2018

Hyojin Kim

3

1 reference

27 May 2018

Jin-Haeng Chung

6

1 reference

27 May 2018

publication date

5 December 2012

1 reference

27 May 2018

published in

Cancer Cytopathology

1 reference

27 May 2018

volume

121

1 reference

27 May 2018

issue

6

1 reference

27 May 2018

page(s)

311-319

1 reference

27 May 2018

Personalized Combined Modality Therapy for Locally Advanced Non-small Cell Lung Cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Crizotinib for ALK-rearranged non-small cell lung cancer: a new targeted therapy for a new target

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EML4-ALK fusion gene and efficacy of an ALK kinase inhibitor in lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Lung adenocarcinoma: guiding EGFR-targeted therapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR mutation is a better predictor of response to tyrosine kinase inhibitors in non-small cell lung carcinoma than FISH, CISH, and immunohistochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Reliability of the peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations integrated into the clinical practice for non-small cell lung cancers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR and KRAS mutations detection on lung cancer liquid-based cytology: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Comparison of KRAS and EGFR gene status between primary non-small cell lung cancer and local lymph node metastases: implications for clinical practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Comparison of EGFR and K-RAS gene status between primary tumours and corresponding metastases in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR gene status in cytological samples of nonsmall cell lung carcinoma: controversies and opportunities

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Epidermal growth factor receptor mutation and pathologic-radiologic correlation between multiple lung nodules with ground-glass opacity differentiates multicentric origin from intrapulmonary spread.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Pyrosequencing method to detect KRAS mutation in formalin-fixed and paraffin-embedded tumor tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Pyrosequencing, a method approved to detect the two major EGFR mutations for anti EGFR therapy in NSCLC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Comprehensive epidermal growth factor receptor gene analysis from cytological specimens of non-small-cell lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR mutations are detected comparably in cytologic and surgical pathology specimens of nonsmall cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Biomarkers of response to epidermal growth factor receptor inhibitors in Non-Small-Cell Lung Cancer Working Group: standardization for use in the clinical trial setting.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

EGFR mutation status in primary lung adenocarcinomas and corresponding metastatic lesions: discordance in pleural metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Suitability of endobronchial ultrasound-guided transbronchial needle aspiration specimens for subtyping and genotyping of non-small cell lung cancer: a multicenter study of 774 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

A high frequency of sequence alterations is due to formalin fixation of archival specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

Epidermal growth factor receptor mutation testing in lung cancer: searching for the ideal method

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCY.21260

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1002/CNCY.21260

1 reference

27 May 2018

1 reference

27 May 2018